Sanuwave Health to exhibit dermaPace system at APMA 2019 meeting
SANUWAVE Health announced that the company will exhibit at the American Podiatric Medical Association Annual Scientific Meeting. SANUWAVE will showcase their wound care device system, dermaPACE, to attending podiatrists, physician assistants and other professionals. This will be the first time SANUWAVE will be exhibiting at APMA since the dermaPACE System received FDA clearance in December 2017. The company will be exhibiting in Booth 520. In addition to the exhibition booth, there will be two events involving the dermaPACE system:A poster presentation from Dr. Windy Cole, DPM, Adjunct Professor and Director of Wound Care KSUCPM and Medical Director, UH Ahuja Wound Center titled: The Use of Non-Invasive Pulsed Acoustic Cellular Expression System to Promote Angiogenesis in Chronic Wounds; A Wound Care Workshop on Friday, July 12, 2019 from 1:30 pm - 3:30 pm where Dr. Windy Cole and Dr. James McGuire will be providing a demonstration of the dermaPACE System. The APMA conference will highlight SANUWAVE's innovative presence in the wound care space with the dermaPACE System. This focused Extracorporeal Shockwave Technology, based upon electrohydraulic principle, has been proven in two US based clinical trials enrolling 336 subjects to be safe and effective in the treatment of Diabetic Foot Ulcers. Within a few weeks of initial treatment, wounds treated with dermaPACE reduce in area at superior rates compared to control subjects. The dermaPACE System exhibits superiority in wound area reduction within 12 weeks of initial treatment and exhibits statistical significance in complete wound closure within 20 weeks of initial treatment. The use of the dermaPACE System allows the clinician to more easily, and more cost-effectively, manage wounds. More importantly, the patient's quality of life improves significantly.